Molnlycke Mepilex XT Foam Dressing 20 x 20cm

Product Overview

Mepilex XT is a non-bordered foam dressing that extends the Mepilex platform with integrated exudate channels engineered to absorb both low-viscosity and high-viscosity exudate, a clinically relevant distinction in wounds where exudate contains high fibrinogen or protein content (for example, chronic venous leg ulcers and dehisced surgical wounds). The soft silicone wound-contact layer uses Mölnlycke's Safetac adhesive technology, which adheres to intact peristomal skin but not to the moist wound bed, reducing pain at dressing change and minimising epithelial stripping (Dykes et al., J Wound Care 2001; White, J Wound Care 2005).

The 20 x 20 cm size is appropriate for coverage of sacral pressure ulcers, large trochanteric decubitus, extensive venous ulcers and broad surgical dehiscence where smaller dressings would require multiple overlapping units. The non-bordered format is specifically designed for use with secondary retention (tubular bandage, compression bandaging, or hypoallergenic tape), allowing clinicians to select fixation appropriate to the anatomical location and exudate volume. For Singapore clinicians managing complex wound caseloads in tertiary hospitals, community nursing and long-term care, Mepilex XT is a European Wound Management Association (EWMA) position-document-aligned moist-wound-healing option.

Specifications

Clinical Indications

• Category 2-4 pressure ulcers (EPUAP/NPIAP/PPPIA classification) on sacral, ischial and trochanteric sites requiring broad conformable coverage
• Venous leg ulcers under multilayer compression bandaging (SIGN 120 guideline; compliant with ABPI measurement prerequisite)
• Diabetic foot ulcers (IWGDF Wagner 1-3 or IDSA mild-moderate) requiring moist wound healing without mechanical debridement
• Post-surgical dehisced wounds, skin graft donor sites, and second-degree thermal burns during epithelialisation phase
• Radiation-induced moist desquamation (RTOG grade 2-3) where atraumatic dressing change is clinically essential
• Chronic wounds with viscous or fibrinous exudate where conventional foam dressings strike through prematurely

Frequently Asked Questions

When should Mepilex XT be chosen over Mepilex Border or Mepilex?

Mepilex XT is indicated when viscous or heavy exudate exceeds the absorption capacity of standard Mepilex, or when the wound topography requires the integrated exudate-channel system to distribute fluid across the dressing. Mepilex Border is a self-adherent bordered format for shallow wounds with moderate exudate. Mepilex XT (non-bordered) requires secondary fixation, which is an advantage under compression therapy. Refer to EWMA Position Document on Advanced Wound Dressings for selection logic.

What is Safetac and why is it clinically relevant?

Safetac is a patented soft silicone adhesive layer that forms a seal with intact peri-wound skin without adhering to the moist wound bed. Clinical studies (Meaume et al., J Wound Care 2003; White, J Wound Care 2005) demonstrated that Safetac dressings produce significantly lower pain at dressing change and reduced peri-wound skin damage compared with traditional adhesive dressings, which is particularly important in chronic wound populations where repeated adhesive stripping causes MARSI (medical adhesive-related skin injury).

Is the dressing compatible with topical antimicrobials or enzymatic debriders?

Mepilex XT is compatible with the most commonly used topical antimicrobial preparations (cadexomer iodine, nanocrystalline silver, honey) and enzymatic debriders when used per manufacturer instructions. For heavily colonised or infected wounds, consider Mölnlycke's antimicrobial range (Mepilex Ag, Mepilex Border Ag) which incorporate silver within the foam matrix.

How often should the dressing be changed?

Wear time is determined by exudate volume and clinical assessment, up to a maximum of 7 days. Indicators for change include strike-through staining within 3 cm of the dressing edge, lifting of the adhesive margin, or signs of infection. International Wound Infection Institute (IWII) guidelines on wound infection should be used to guide assessment.

What regulatory and procurement standards apply in Singapore?

Mepilex XT is registered with Singapore Health Sciences Authority (HSA) as a medical device, and is supplied under Essential Medical International Supplies Pte Ltd's dealer licence. The product holds CE marking under MDR 2017/745, US FDA 510(k) clearance, and is manufactured at ISO 13485-certified facilities with ISO 10993 biocompatibility testing.